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Introduction: Risk Scores have been developed for initial stratification of Non-ST-segment elevation acute coronary syndromes. Observational 
studies have reported discrepancies between the estimated risk and the rate of invasive strategies in clinical practice.
Methods: The objective was to evaluate the relationship between the initial TIMI Risk Score (TRS) and the selection of patients for an early invasive 
strategy, and to explore the influence of other variables not included in risk scores over this strategy.
Results: Between October 2006 and May 2008, 1396 patients with Non-ST segment elevation acute coronary syndrome were admitted in 37 
Institutions from 11 Argentine provinces. According to TRS stratification, 129 patients (9.2%) were considered as high risk, 740 (53%) as moderate 
risk and 527 (37.8%) as low risk. Early invasive strategy was applied to 742 patients (53.2%); according to TRS were 57.4%, 55.5% and 48.8% in 
high, moderate and low risk groups respectively (p trend < 0.05). The area under the ROC curve (C index) of the TRS to predict early invasive strategy 
was 0.55. In multivariate analysis the selection for an early invasive strategy was associated with prior angioplasty OR 1.6(1.2-2.2), prior CABG OR 
0,6 (0.5-0.9), age OR 0.98 (0.98-0.99), hypercholesterolemia 1.4 (1.1-1.7), ST-segment changes 1.5 (1.2-1.9), elevated cardiac biomarkers 1.4 
(1.1-1.8), cath lab availability in the Institution OR 1.7 (1.3-2), early recurrent or refractory angina 3.5 (2.3-5) and history of heart failure OR 0.4 
(0.2-0.7). The model conformed by this variables was called “medical judgment”. The C index for the “medical judgment” model was 0.68, p<0.0001 
vs. C Index 0.55 of the TRS. Medical judgment model was better predictor of inhospital mortality than TRS, with a C Index of 0.85 (vs. 0.62 of the 
TRS), p<0.0001.
Conclusion: The selection of patients with non-STE ACS for an early invasive strategy, is guided by many variables not included in TRS score. Other 
variables included in this decision model, particularly early recurrence of ischemia, may partially explain the discordance reported between risk of 
patients as evaluated according to risk scores and the selection for an invasive strategy.
